References
- Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861–1874.
- Akter S, Jahan I, Khatun MR, et al. Pharmacological insights into Merremia vitifolia (burm.f.) hallier f. leaf for its antioxidant, thrombolytic, anti-arthritic and anti-nociceptive potential. Biosci Rep. 2021;41(1):BSR20203022.
- Tan J, Deng Z, Liu G, et al. Anti-inflammatory polymersomes of redox-responsive polyprodrug amphiphiles with inflammation-triggered indomethacin release characteristics. Biomaterials. 2018;178:608–619.
- Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15(Suppl 3):S2.
- Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care. 2018;45(2):237–255.
- Feng X, Liu J, Xu W, et al. Tackling autoimmunity with nanomedicines. Nanomedicine. 2020;15(16):1585–1597.
- Feng X, Xu W, Li Z, et al. Immunomodulatory nanosystems. Adv Sci. 2019;6(17):1900101.
- Gadeval A, Chaudhari S, Bollampally SP, et al. Integrated nanomaterials for non-invasive photothermal therapy of rheumatoid arthritis. Drug Discov Today. 2021;26(10):2315–2328.
- Lu Y, Li L, Lin Z, et al. A new treatment modality for rheumatoid arthritis: combined photothermal and photodynamic therapy using Cu7.2 S4 nanoparticles. Adv Healthc Mater. 2018;7(14):e1800013.
- Gao Y, Yu G, Xing K, et al. Finely tuned Prussian blue-based nanoparticles and their application in disease treatment. J Mater Chem B. 2020;8(32):7121–7134.
- Zhang S, Wu L, Cao J, et al. Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy. Colloids Surf B Biointerfaces. 2018;170:224–232.
- Sahu A, Jeon J, Lee MS, et al. Antioxidant and anti-inflammatory activities of Prussian blue nanozyme promotes full-thickness skin wound healing. Mater Sci Eng C Mater Biol Appl. 2021;119:111596.
- Cai X, Gao W, Ma M, et al. A Prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-Responsive longitudinal relaxivity. Adv Mater. 2015;27(41):6382–6389.
- Liu B, Wang W, Fan J, et al. RBC membrane camouflaged Prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer. Biomaterials. 2019;217:119301.
- Fang RH, Kroll AV, Gao W, et al. Cell membrane coating nanotechnology. Adv Mater. 2018;30(23):e1706759.
- Liu Y, Luo J, Chen X, et al. Cell membrane coating technology: a promising strategy for biomedical applications. Nanomicro Lett. 2019;11(1):100.
- Long Y, Wang Z, Fan J, et al. A hybrid membrane coating nanodrug system against gastric cancer via the VEGFR2/STAT3 signaling pathway. J Mater Chem B. 2021;9(18):3838–3855.
- Hou M, Wei Y, Zhao Z, et al. Immuno-engineered nanodecoys for the multi-target anti-inflammatory treatment of autoimmune diseases. Adv Mater. 2022;:e2108817. doi:https://doi.org/10.1002/adma.202108817.
- Li R, He Y, Zhu Y, et al. Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett. 2019;19(1):124–134.
- Zhou M, Hou J, Zhong Z, et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv. 2018;25(1):716–722.
- Liu Y, Jin J, Xu H, et al. Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy. Acta Biomater. 2021;121:541–553.
- Zhou H, You P, Liu H, et al. Artemisinin and procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Control Release. 2022;341:828–843.
- Jiang Q, Liu Y, Guo R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors. Biomaterials. 2019;192:292–308.
- Wang D, Dong H, Li M, et al. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano. 2018;12(6):5241–5252.
- Zhang X, Servos MR, Liu J. Fast pH-assisted functionalization of silver nanoparticles with monothiolated DNA. Chem Commun. 2012;48(81):10114–10116.
- Cai X, Wong YF, Zhou H, et al. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol. 2006;373(2):140–147.
- Belmellat N, Semerano L, Segueni N, et al. Tumor necrosis factor-alpha targeting can protect against arthritis with low sensitization to infection. Front Immunol. 2017;8:1533.
- Levick JR. Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol. 1990;17(5):579–582.
- Siniavin AE, Streltsova MA, Kudryavtsev DS, et al. Activation of α7 nicotinic acetylcholine receptor upregulates HLA-DR and macrophage receptors: potential role in adaptive immunity and in preventing immunosuppression. Biomolecules. 2020;10(4):507.
- Rao L, Wu L, Liu Z, et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat Commun. 2020;11(1):4909.
- Gholibegloo E, Karbasi A, Pourhajibagher M, et al. Carnosine-graphene oxide conjugates decorated with hydroxyapatite as promising nanocarrier for ICG loading with enhanced antibacterial effects in photodynamic therapy against Streptococcus mutans. J. Photochem. Photobiol. B Biol. 2018;181:14–22.
- Li ZH, Chen Y, Sun Y, et al. Platinum-Doped Prussian blue nanozymes for multiwavelength bioimaging guided photothermal therapy of tumor and anti-Inflammation. ACS Nano. 2021;15(3):5189–5200.
- Xie X, Zhao J, Gao W, et al. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-κB signaling pathway. Theranostics. 2021;11(7):3213–3228.
- Long Y, Wu X, Li Z, et al. PEGylated WS2 nanodrug system with erythrocyte membrane coating for chemo/photothermal therapy of cervical cancer. Biomater Sci. 2020;8(18):5088–5105.
- Kang H, Hu S, Cho MH, et al. Theranostic nanosystems for targeted cancer therapy. Nano Today. 2018;23:59–72.
- Xue W, Liu Y, Zhang N, et al. Effects of core size and PEG coating layer of iron oxide nanoparticles on the distribution and metabolism in mice. Int J Nanomed. 2018;13:5719–5731.
- Yang Y, Guo L, Wang Z, et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials. 2021;264:120390.
- Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;339(6116):166–172.
- Khojah HM, Ahmed S, Abdel-Rahman MS, et al. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants. Free Radic Biol Med. 2016;97:285–291.
- Jiulong Z, Xiaojun C, Wei G, et al. Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl Mater Interfaces. 2018;10(31):26108–26117.
- Suzuki S, Kokumai T, Tanahashi Y, et al. Protein ingestion can significantly affect glucagon secretion along with blood urea nitrogen alteration in type 1 diabetes. J Diabetes Investig. 2021;12(2):293–294.
- Ahmed EA, Ahmed OM, Fahim HI, et al. Potency of bone marrow-derived mesenchymal stem cells and indomethacin in complete Freund's adjuvant-induced arthritic rats: roles of TNF-α, IL-10, iNOS, MMP-9, and TGF-β1. Stem Cells Int. 2021;2021:6665601.